<?xml version="1.0" encoding="UTF-8"?>
<p id="Par51">Power calculations were undertaken to ensure that the minimal detectable difference in the two primary endpoint rates, given that the projected sample size was well within the expected given prior literature [
 <xref ref-type="bibr" rid="CR15">15</xref>]. For one-year retention, 1160 patients in the primary study population were projected to enroll during the EAAA (intervention) phase and 2088 under the control phase in the first 24Â months to achieve a one-year follow-up.
</p>
